Detection of EGFR T790M in EGFR activating mutation-positive advanced non-small cell lung cancer (NSCLC): Comparison between two assays on circulating tumour (ct)DNA

被引：0
|
作者：
Charpentier, S. [1 ]
Herbreteau, G. [1 ]
Vallee, A. [1 ]
Henaff, D. [2 ]
Grewis, L. [2 ]
Denis, M. G. [3 ]
机构：
[1] CHU Nantes, Hotel Dieu, Biochim Plateforme Genet Canc, Nantes, France
[2] ID Solut, Grabels, France
[3] CHU Nantes, Hotel Dieu, Biochem Dept, Nantes, France
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1354P
引用
收藏
页码：S868 / S868
页数：1
相关论文
共 50 条
  • [1] Detection of EGFR T790M in Asia-Pacific patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): Circulating tumour (ct) DNA analysis across 3 platforms
    Zhou, C.
    Wang, M.
    Cheng, Y.
    Chen, Y.
    Ye, X.
    Sun, Y.
    Huang, X.
    Patel, S.
    Chen, Y.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Osimertinib for EGFR T790M mutation-positive non-small cell lung cancer
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Hirano, Toshiyuki
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (01) : 31 - 38
  • [3] Plasma ctDNA analysis for detection of EGFR T790M mutation in patients (pts) with EGFR mutation-positive advanced non-small cell lung cancer (aNSCLC)
    Jenkins, S.
    Yang, J.
    Ramalingam, S.
    Yu, K.
    Patel, S.
    Weston, S.
    Lawrance, R.
    Cantarini, M.
    Janne, P.
    Mitsudomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S153 - S154
  • [4] An evaluation of aumolertinib for the treatment of EGFR T790M mutation-positive non-small cell lung cancer
    Wang, Jingyi
    Wu, Lin
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (06) : 647 - 652
  • [5] Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Khozin, Sean
    Weinstock, Chana
    Blumenthal, Gideon M.
    Cheng, Joyce
    He, Kun
    Zhuang, Luning
    Zhao, Hong
    Charlab, Rosane
    Fan, Ingrid
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2017, 23 (09) : 2131 - 2135
  • [6] Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer
    Skoulidis, Ferdinandos
    Papadimitrakopoulou, Vassiliki A.
    CLINICAL CANCER RESEARCH, 2017, 23 (03) : 618 - 622
  • [7] Detection of T790M Mutation in Circulating Free Tumor DNA of Patients with EGFR-Positive Advanced Non-Small Cell Lung Cancer
    Veccia, A.
    Girlando, S.
    Dipasquale, M.
    Barbareschi, M.
    Caffo, O.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2390 - S2390
  • [8] Non-Small Cell Lung Cancer with Resistance to EGFR-TKI Therapy: CT Characteristics of T790M Mutation-positive Cancer
    Koo, Hyun Jung
    Kim, Mi Young
    Park, Sojung
    Lee, Han Na
    Kim, Hwa Jung
    Lee, Jae Cheol
    Kim, Sang-We
    Lee, Dae Ho
    Choi, Chang-Min
    RADIOLOGY, 2018, 289 (01) : 227 - 237
  • [9] EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Sakakibara, Rie
    Saiki, Masafumi
    Ariyasu, Ryo
    Koyama, Junji
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Ohyanagi, Fumiyoshi
    Ninomiya, Hironori
    Ishikawa, Yuichi
    Nishio, Makoto
    RESPIRATORY MEDICINE CASE REPORTS, 2018, 24 : 19 - 21
  • [10] Clinical implementation of circulating tumour DNA testing for EGFR T790M for detection of treatment resistance in non-small cell lung cancer
    Spence, Tara
    Perera, Sheron
    Weiss, Jessica
    Grenier, Sylvie
    Ranich, Laura
    Shepherd, Frances
    Stockley, Tracy L.
    JOURNAL OF CLINICAL PATHOLOGY, 2021, 74 (02) : 91 - 97
12345